Exponent Stock Price and Value Analysis

Exponent (NasdaqGS:EXPO) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Exponent to reach your target.

Target type

EXPO Free Cash Flow Trend

Free Cash Flow trendline for EXPO
Free Cash Flow trendline for Exponent
CSV

Based on historical returns, we believe that Exponent can grow its free cash at a rate of about 22%. That's positive!

AdvantagesDisadvantages
  • This company has stable growth.
  • This company is making money at a great rate!
  • This company is solid.
  • This company has a low dividend yield.
  • This stock looks overpriced.

Inside the EXPO Numbers

EXPO Price
(Exponent stock price per share)
$89.16
[?] EXPO Fair Price
(based on intrinsic value)
$79.10
[?] EXPO Safety Price (based on a variable margin of safety) $51.41
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 192% higher than other Industrials stocks
[?] PE Ratio versus Industry 89% higher than other Consulting Services stocks
[?] Cash Yield 1.43%
[?] Free Cash Flow Jitter 14%
[?] Dividend Yield 1.38% (tax impact)
Shares Shorted 2,421,641

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,421,641 shares shorted. With 46,909,068 shares available for purchase and an average trading volume over the past 10 trading days of 345,410, it would take at least 7.0 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 851520 24.8
2010 851520 33.8
2011 851520 43.8
2012 851520 45.2
2013 851520 57.9
2014 851520 43.8
2015 851520 55.4
2016 851520 59.8
2017 851520 60.7
2018 851520 82
2019 851520 95.3
2020 851520 90.6
2021 851520 113
2022 851520 81.2
2023 851520 115
2024 851520 135
2025 851520 121

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2009 to 2025 with positive net income, operating cash flow totaled $1,388 million against net income of $1,087 million, or 1.28 times.

In 2025, operating cash flow was 1.24 times net income, compared with 1.33 times for the earliest three years (2009 to 2011).

In 2025, capital expenditures were $9.4 million, 7.1% of operating cash flow of $132 million, which leaves an estimated $122 million after capex. Across the 17 years with reported capex, it averaged 10.4% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 22.1 26.8 2 1.21
2010 27.5 36.1 2.5 1.31
2011 32.7 46.6 3.8 1.43
2012 37.2 48.5 4.9 1.30
2013 38.6 61.8 6.2 1.60
2014 40.7 48.3 4.9 1.19
2015 43.6 60.5 5.4 1.39
2016 47.5 66.9 14.4 1.41
2017 41.3 67.8 4.7 1.64
2018 72.3 91.2 16.3 1.26
2019 82.5 108 23 1.31
2020 82.6 103 5 1.25
2021 101 125 6.8 1.23
2022 102 93.8 12 0.92
2023 100 127 16.4 1.27
2024 109 145 6.9 1.33
2025 106 132 9.4 1.24

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $954 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $407 million, 42.7% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.

In 9 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $410 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $159 million, 130.6% of estimated free cash flow of $121 million. That was more than the estimated free cash flow of the year.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 59.8 18.8 24.5 43.2 72.3%
2017 60.7 21.8 11.9 33.8 55.6%
2018 82 27.2 27.9 55.1 67.2%
2019 95.3 33.5 22 55.5 58.2%
2020 90.6 39.8 40 79.8 88.1%
2021 113 43.2 7 50.2 44.3%
2022 81.2 49.2 156 205 252.7%
2023 115 54 24.2 78.3 68.2%
2024 135 58.2 5.7 63.9 47.3%
2025 121 61.5 97.1 159 130.6%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $228 million in 2009 and $582 million in 2025, a compound annual growth rate of 6.0% over 16 years.

Revenue rose 4.2% from 2024 to 2025.

Our estimated free cash flow was $121 million in 2025, 20.9% of revenue. In 2009 the estimated margin was 10.9%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2009 228 24.8 10.9%
2010 249 33.8 13.6%
2011 272 43.8 16.1%
2012 293 45.2 15.4%
2013 296 57.9 19.5%
2014 305 43.8 14.4%
2015 313 55.4 17.7%
2016 315 59.8 19.0%
2017 348 60.7 17.5%
2018 380 82 21.6%
2019 417 95.3 22.8%
2020 400 90.6 22.7%
2021 466 113 24.3%
2022 513 81.2 15.8%
2023 537 115 21.4%
2024 559 135 24.2%
2025 582 121 20.9%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $222 million against total liabilities of $387 million, or 57.3% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 49.8% of total assets in 2025, compared with 29.0% in 2010, an increase of 20.8 percentage points.

Stockholders equity was $390 million in 2025, compared with $184 million in 2010, a rise of 112.4%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 32.2% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2010 259 107 75.1 184
2011 269 84.4 82.1 187
2012 315 113 99 216
2013 344 123 109 235
2014 365 129 121 244
2015 388 126 125 263
2016 404 115 130 273
2017 440 125 151 289
2018 469 127 155 314
2019 563 176 213 350
2020 580 198 219 361
2021 684 298 267 417
2022 587 161 266 321
2023 647 187 291 356
2024 777 259 356 421
2025 778 222 387 390

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $89.16, our model's value equals that price if free cash flow grows an average of 23.6 percent a year over the 10 projection years. Our model assumes 21.7 percent a year for this stock, so the price implies growth of 23.6 percent, which is above the 21.7 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

At 23.6 percent a year, free cash flow would grow about 8.3 times over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $60.6 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $71.33 20.1%
Current price $89.16 23.6%
20 percent above the current price $106.99 26.4%
Our model (stored fair price) $79.10 21.7%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Every one of the 17 fiscal years we have for Exponent under its current filer shows positive free cash flow.

At $89.16, the price is above our fair value estimate of $79.10 for Exponent.

Comparing the first and last three years of data, average free cash flow rose sharply: $34.1 million at the start and $124 million most recently.

Free cash flow is fairly steady from year to year, with a variability measure of 14%.

The dividend yield for Exponent is 1.38%.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 192% above the average for stocks in the Industrials sector.

Its trailing P/E ratio is 89% above the average for stocks in the Consulting Services industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Consulting Services industry, the ones closest in market capitalization to Exponent, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Exponent (EXPO) 4,240 38.4 1.4% 1.4% 13% above
FTI Consulting (FCN) 5,605 25.6 - 2.7% 26% above
Genpact Limited (G) 6,940 12.1 1.8% 5.2% 35% below
ICF International (ICFI) 1,392 14.6 0.7% 7.9% 53% below
The Hackett Group (HCKT) 312 18.2 3.9% 11.5% 80% below
The RMR Group (RMR) 272 25.9 11.0% - 21% above
Mastech Digital (MHH) 70.9 65.5 - - 21% below

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 851520.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: EXPO annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in EXPO

Does Exponent have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: EXPO

This example shows how we apply the Trendshare checklist to EXPO: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 89.16
    • Market cap: $4.2B
    • EPS: 2.32
  2. Step 2 — Valuation checks

    • P/E: 38.431
    • FCF yield: 1.4%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.